Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data

INTRODUCTION: Triptans, the most commonly prescribed acute treatments for migraine attacks are, per FDA labeling, contraindicated in cardiovascular (CV) disease patients and have warnings and precautions for those with CV risk factors. METHODS: Headache specialists, cardiologists, and health economi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Prim Care Community Health
Main Authors: Dodick, David W., Shewale, Anand S., Lipton, Richard B., Baum, Seth J., Marcus, Steven C., Silberstein, Stephen D., Pavlovic, Jelena M., Bennett, Nathan L., Young, William B., Viswanathan, Hema N., Doshi, Jalpa A., Weintraub, Howard
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7585888/
https://ncbi.nlm.nih.gov/pubmed/33095099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2150132720963680
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki